Nontuberculous Mycobacteria Lung Disease: Management Strategies for Advanced Practice Providers

Released On
December 15, 2021

Expires On
December 15, 2022

Media Type
Internet

Completion Time
60 minutes

Specialty
Critical Care, Infectious Disease, Pulmonology, Respiratory

Topic(s)
Lung Disease

Scroll to the Bottom of this Information to Begin this Course

This activity is jointly provided by Potomac Center for Medical Education and Rockpointe.


 

In collaboration with Chest Foundation

 

Supported by an educational grant from Insmed.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credits
  • Nurses — 1.0 Contact Hours
  • Physician Assistants — maximum of 1.0 contact hour(s)

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

The intended audience for this educational initiative is nurse practitioners and physician assistants who manage patients with NTM-LD.

Program Overview

Nontuberculous mycobacterium lung disease (NTM-LD) is associated with significant morbidity and mortality with 5-year survival rates similar to that of patients with lung cancer. The incidence and prevalence of has risen dramatically in recent decades, straining the management capacity of the limited number of pulmonologist and infectious disease physicians. Thus, the role of advanced practice providers (APP), such as nurse practitioners and physician assistants, will become even more important as they take on more responsibilities in diagnosing and managing patients with NTM-LD. Based on recent conversations with NTM physicians and APPs, as well as practice pattern studies of pulmonologists, there are multiple gaps in knowledge, skills, and attitudes regarding the diagnosis and management of NTM-LD.

Nontuberculous Mycobacteria Lung Disease: Management Strategies for Advanced Practice Providers will address the gaps in NTM-LD care by reviewing current evidence-based criteria for diagnosis and recommendations for treatment. Content will be developed by expert physicians and APPs who manage patients with NTM-LD daily and understand the barriers and issues that APPs confront in the complex nature of NTM diagnosis and treatment.

Click here to view the Patient Resources provided by CHESTFoundation

Agenda

  • Welcome and Introduction
  • Advanced Practice Provider Roles in the Diagnostic Process for NTM-LD
  • Advanced Practice Provider Roles in Treatment Strategies for NTM-LD
  • Q & A Session and Activity Roundup

Learning Objectives

At the conclusion of an activity, participants should be able to:

  • Recognize patient risk factors for NTM lung disease
  • Accurately interpret testing results required for diagnosing NTM-LD
  • Communicate effectively with patients regarding the diagnosis of NTM-LD
  • Implement evidence-based strategies for managing and monitoring side effects of NTM-LD therapies
  • Educate patients undergoing NTM treatment about selected treatments, related side effects, monitoring strategies, and treatment adherence

Faculty

Doreen Addrizzo-Harris, MD

Professor of Medicine
Associate Division Director for Clinical and Academic Affairs
Program Director, Pulmonary & Critical Care Fellowship
Division of Pulmonary Critical Care & Sleep Medicine
NYU School of Medicine
New York, NY

Doreen Addrizzo-Harris, MD is a Professor of Medicine at NYU School of Medicine. She completed her medical degree and fellowship training at NYU School of Medicine and joined the faculty in 1996. She has served as Program Director of the Pulmonary Critical Care Fellowship since 2001. She has grown the fellowship to over 27 fellows over the last 20 years. Dr. Addrizzo-Harris served as Interim Director of the NYU Langone Division of Pulmonary, Critical Care and Sleep Medicine in 2014, and now is the Associate Division Director for Clinical and Faculty Affairs. She is Co-director of the Faculty Group Practice which comprises more than 20 physicians. In addition to her love for medical education, Dr. Addrizzo-Harris is Co-director of the NYU Bronchiectasis Center and specializes in non-CF bronchiectasis and the treatment of nontuberculous mycobacterial pulmonary disease. She is PI of the NYU Bronchiectasis Registry and PI for the US Bronchiectasis Research Registry as well as numerous clinical trials.

Dr. Addrizzo-Harris is involved at the national level and has held many leadership roles at CHEST. She is currently the President- Designate of the American College of Chest Physicians and is a member of the CHEST Board of Regents. She is the past President of the CHEST Foundation and the immediate Past Chair of the Professional Standards Committee. In the past she served as Program Director of the Annual meeting in 2012 in Atlanta and Chair of the Guidelines Oversight Committee for CHEST. She is also very involved with the Association of Pulmonary and Critical Care Medicine Program Directors (APCCMPD) and served on its Board for more than 10 years as the President and Secretary-Treasurer.

Jeremy Amayo, MMSc, PA-C

Director of Ultrasound Education
Assistant Professor
Emory University School of Medicine
PA, Pulmonary/Critical Care Medicine
Emory Center for Critical Care
Atlanta, GA

Jeremy Amayo, MMSc, PA-C is the director of ultrasound education, assistant professor, and a critical care PA at the Emory University School of Medicine where he teaches pulmonary medicine, clinical endocrinology, physiology, and point of care ultrasound. He has won multiple awards for his innovative and engaging teaching style and has implemented several novel active learning strategies to improve PA student competency in the basic sciences and pulmonology. As an early-career researcher, he is interested in metacognitive judgments that students make about their own competency when engaged in a learning task. You will usually find him with an ultrasound probe in one hand and a coffee in the other.

Charles L. Daley, MD

Professor of Medicine
Chief, Division of Mycobacterial and Respiratory Infections D
epartment of Medicine
National Jewish Health
Denver, CO

Charles L. Daley, MD is Professor of Medicine at National Jewish Health (NJH), the University of Colorado, and Icahn School of Medicine at Mount Sinai. He is Chief of the Division of Mycobacterial and Respiratory Infections and Director of the Nontuberculous Mycobacteria (NTM) Center of Excellence at NJH. Dr. Daley has served on expert panels for the WHO, Centers for Disease Control and Prevention, Infectious Diseases Society of America and American Thoracic Society. In these roles he has served on guideline development committees for diagnosis, treatment and prevention of TB including as Chair of the multi-society NTM Guidelines. Dr. Daley has been recognized as one of the “Best Doctors in America” by U.S. News & World Report and Castle Connolly and he received the World Lung Health Award given by the American Thoracic Society. He was previously Associate Editor of the American Journal of Respiratory and Critical Care Medicine and currently Associate Editor of The European Respiratory Journal. His academic interests include global health policy and clinical and translational research in tuberculosis and NTM infections.

Jennifer Faber-Gerling, RN, MS, CNS, ANP-BC

Division of Mycobacterial and Respiratory Infections
National Jewish Health
Denver, CO

Jennifer Faber-Gerling, RN, MS, CNS, ANP-BC completed her undergraduate BSN at the University of Rochester, Rochester New York. She first functioned as a staff RN with a focus of pulmonary care. She also obtained experience as an operative RN and cardiothoracic surgery case manager. She completed her first masters as a Clinical Nurse Specialist (CNS) at the University of Colorado College of Nursing and served as CNS educator supporting RNs working with pulmonary hypertension, lung transplant acquired infections, cystic fibrosis, and thoracic surgery.

Jennifer has been practicing at National Jewish Health since May of 2013 in the Division of Mycobacterial and Respiratory Infections during which time she completed her second master’s as a Nurse Practitioner (NP) at the University of Colorado College of Nursing. In this role she works with a collaborative team of physicians, respiratory therapists, dieticians and nurses to service a primarily out- of-state patient population with pulmonary and extrapulmonary mycobacterial infections and bronchiectasis.

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation Statement

The Potomac Center for Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Association of Nurse Practitioners (AANP) Credit Designation

This activity is approved for 0.90 contact hour(s) of continuing education (which includes 0.50 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 21115269. This activity was planned in accordance with AANP Accreditation Standards and Policies.

American Association of Physician Assistants (AAPA) Credit Designation

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 12/15/2021 to 12/15/2022. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-203989.

For questions regarding CME credit or the evaluation, please email contact@potomacme.org.

Disclosure Information

Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other relevant professional organizations, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of an accredited continuing education program provided by the Potomac Center for Medical Education are required to disclose to PCME all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by PCME in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by PCME to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by PCME.

Faculty, Authors, and Content Developers
The faculty, authors and content developers reported the following relevant financial relationships with ineligible companies:

Doreen Addrizzo-Harris, MD

  • Contracted Research: Hillrom, Insmed, Zambon

Jeremy Amayo, MMSc, PA-C: has no relevant financial relationships.

Charles L. Daley, MD

  • Consultanting Fee: AN2 Therapeutics, Insmed, Matinas, Paratek, Spero Therapeutics
  • Contracted Research: Insmed, BugWorks

Jennifer Faber-Gerling, RN, MS, CNS, ANP-BC

  • Speaker's Bureau: Insmed

Planners and Managers
The planners and managers reported the following relevant financial relationships with ineligible companies:

Chad Williamson, MS, MBA, CMPP: has no relevant financial relationships.

Content Reviewers
The content reviewers reported the following financial relationships with ineligible companies:

Katie Propst, PhD: has no relevant financial relationships.

Instructions for Participation and Credit

There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME activity in its entirety, and then complete the post-test, with a score of 70% or better, and evaluation. The estimated time for completion of this activity is 1 hour. To receive their certificates, participants must demonstrate mastery of the presented material via the post-test. Participant is allowed to take the post-test multiple times.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

FDA DISCLOSURE
The contents of some CME activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Contact Information

For questions regarding CME credit or the evaluation, please email contact@potomacme.org.